Veru Inc. announced the appointment of David D. Ho, M.D. as Chairman of its Scientific Advisory Board (SAB). David D. Ho, M.D., is the Founding Scientific Director of the Aaron Diamond AIDS Research Center and the Clyde and Helen Wu Professor of Medicine at Columbia University Irving Medical Center, a Member of The National Academy of Medicine, as well as a Member of The American Academy of Arts & Sciences, and a Fellow of The American Association for the Advancement of Science. He received his M.D. from Harvard Medical School and has received fourteen honorary doctorates over the course of his career.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.23 USD | -3.15% | -6.82% | +70.83% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+70.83% | 18Cr | |
+81.87% | 33Cr | |
+15.75% | 19Cr | |
+16.49% | 9.25Cr | |
+6.90% | 6.65Cr |
- Stock Market
- Equities
- VERU Stock
- News Veru Inc.
- Veru Inc. Appoints David D. Ho as Chairman of Its Scientific Advisory Board